{
  "id": 714,
  "text": "0 5 } ^ { \\cdot }$ ).There were no port-site recurrence, nor was there a difference in the pattern of recurrences between the two procedures.In the identified study694 comparing VALRH and LARVH, no difference with respect to the 5- year recurrence-free survival rate and OS for FIGO stage IB1 cervical cancer were reported ( $9 2 .",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 0 5 } ^ { \\cdot }$ ).There were no port-site recurrence, nor was there a difference in the pattern of recurrences between the two procedures.In the identified study694 comparing VALRH and LARVH, no difference with respect to the 5- year recurrence-free survival rate and OS for FIGO stage IB1 cervical cancer were reported ( $9 2 .\n\n<question>: ",
  "ChatGPT_response_0": "在对第一期宫颈癌进行VALRH和LARVH手术比较的研究中，关于5年复发生存率和总生存率的结果是一致的。根据研究显示，对于FIGO分期IB1宫颈癌，两种手术方式在5年的复发生存率和总生存率方面并无显著差别。这意味着无论是VALRH还是LARVH手术，对于第一期宫颈癌患者的生存结果没有明显差异。",
  "query": "在对第一期宫颈癌进行VALRH和LARVH手术比较的研究中，有关5年复发生存率和总生存率的结果是否一致？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在对第一期宫颈癌进行VALRH和LARVH手术比较的研究中，有关5年复发生存率和总生存率的结果是否一致？\n\n<reference text>: 0 5 } ^ { \\cdot }$ ).There were no port-site recurrence, nor was there a difference in the pattern of recurrences between the two procedures.In the identified study694 comparing VALRH and LARVH, no difference with respect to the 5- year recurrence-free survival rate and OS for FIGO stage IB1 cervical cancer were reported ( $9 2 .\n\n<reply>: ",
  "response": "在对第一期宫颈癌进行VALRH和LARVH手术比较的研究中，关于5年复发生存率和总生存率的结果是一致的。根据研究显示，对于FIGO分期IB1宫颈癌，两种手术方式在5年的复发生存率和总生存率方面并无显著差别。这意味着无论是VALRH还是LARVH手术，对于第一期宫颈癌患者的生存结果没有明显差异。"
}